Eagle Pharmaceuticals Stock Options

EGRX Stock  USD 5.79  0.08  1.36%   
Eagle Pharmaceuticals' latest option contracts expiring on 2024-08-16 are carrying combined implied volatility of 88.43 with a put-to-call open interest ratio of 0.15 over 8 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-08-16.

Open Interest Against 2024-08-16 Option Contracts

Eagle Pharmaceuticals option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Eagle Pharmaceuticals' lending market. For example, when Eagle Pharmaceuticals' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Eagle Pharmaceuticals, he or she must hedge the risk by shorting Eagle Pharmaceuticals stock over its option's life.
The chart above shows Eagle Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Eagle Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Eagle Pharmaceuticals' option, there is no secondary market available for investors to trade.
Eagle Pharmaceuticals' option chain provides insight into all available option contracts written on Eagle Pharmaceuticals' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Eagle Pharmaceuticals' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Eagle option contract.

In The Money vs. Out of Money Option Contracts on Eagle Pharmaceuticals

Analyzing Eagle Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in Eagle Pharmaceuticals regardless of its overall volatility. This is especially true when Eagle Pharmaceuticals' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Eagle Pharmaceuticals' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Eagle Pharmaceuticals' stock while costing only a fraction of its price.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eagle Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Eagle Stock please use our How to Invest in Eagle Pharmaceuticals guide.At this time, Eagle Pharmaceuticals' Liabilities And Stockholders Equity is fairly stable compared to the past year. Stock Based Compensation To Revenue is likely to rise to 0.06 in 2024, whereas Total Stockholder Equity is likely to drop slightly above 138 M in 2024.

Eagle Current Options Market Mood

Eagle Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Eagle Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Eagle Pharmaceuticals' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Eagle Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Eagle Pharmaceuticals' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Rule 16 of the current Eagle contract

Base on the Rule 16, the options market is currently suggesting that Eagle Pharmaceuticals will have an average daily up or down price movement of about 5.53% per day over the life of the 2024-08-16 option contract. With Eagle Pharmaceuticals trading at USD 5.79, that is roughly USD 0.32. If you think that the market is fully incorporating Eagle Pharmaceuticals' daily price movement you should consider buying Eagle Pharmaceuticals options at the current volatility level of 88.43%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Eagle Pharmaceuticals options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Eagle calls. Remember, the seller must deliver Eagle Pharmaceuticals stock to the call owner when a call is exercised.

Eagle Pharmaceuticals Option Chain

When Eagle Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Eagle Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Eagle Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Eagle. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Eagle. It also shows strike prices and maturity days for a Eagle Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
DeltaGammaOpen IntExpirationCurrent SpreadLast Price
Call
2024-08-16 CALL at $2.50.90690.024922024-08-162.0 - 3.93.6In
Call
2024-08-16 CALL at $5.00.78920.20461122024-08-160.95 - 1.451.08In
 Put
2024-08-16 PUT at $5.0-0.27750.1284132024-08-160.1 - 1.050.18Out
 Put
2024-08-16 PUT at $7.5-0.66560.159752024-08-161.5 - 2.552.48In
 Put
2024-08-16 PUT at $10.0-0.71790.095602024-08-162.95 - 6.20.0In

Eagle Pharmaceuticals Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

Eagle Pharmaceuticals Market Cap Over Time

   Market Cap   
       Timeline  

Eagle Total Stockholder Equity

Total Stockholder Equity

137.97 Million

At this time, Eagle Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year.

Eagle Pharmaceuticals Corporate Management

Additional Tools for Eagle Stock Analysis

When running Eagle Pharmaceuticals' price analysis, check to measure Eagle Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eagle Pharmaceuticals is operating at the current time. Most of Eagle Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eagle Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eagle Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eagle Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.